 BETHLEHEM, Pa., Sept. 20, 2021 GLOBE NEWSWIRE -- OraSure Technologies, Inc. NASDAQ: OSUR, a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Defense Logistics Agency has awarded the Company a procurement contract for its InteliSwabTM COVID-19 Rapid Test for over-the-counter use, which the Defense Logistics Agency estimated to have a value of 205 million. Under the terms of the contract, OraSure will provide its InteliSwabTM COVID-19 Rapid Test to up to 25,000 sites throughout the United States and the tests will be funded by the U.S. federal government. The contract will run from October 2021 through September 2022. 